acetovanillone has been researched along with Alzheimer Disease in 6 studies
apocynin : An aromatic ketone that is 1-phenylethanone substituted by a hydroxy group at position 4 and a methoxy group at position 3.
Alzheimer Disease: A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57)
| Excerpt | Relevance | Reference |
|---|---|---|
| " In the present work, the chronic administration (6 weeks) of scopolamine was used to analyze the neuroprotective effects of apocynin and galantamine." | 1.56 | Neuroprotective Effects of Apocynin and Galantamine During the Chronic Administration of Scopolamine in an Alzheimer's Disease Model. ( Correa-Basurto, J; Farfán-García, ED; Fragoso-Vázquez, MJ; García-Marín, ID; Gómez-López, M; Joseph, E; Miliar-García, Á; Rosales-Hernández, MC; Torres-Ramos, MA; Villalobos-Acosta, DMÁ, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Du, F | 1 |
| Yu, Q | 1 |
| Swerdlow, RH | 1 |
| Waites, CL | 1 |
| Joseph, E | 1 |
| Villalobos-Acosta, DMÁ | 1 |
| Torres-Ramos, MA | 1 |
| Farfán-García, ED | 1 |
| Gómez-López, M | 1 |
| Miliar-García, Á | 1 |
| Fragoso-Vázquez, MJ | 1 |
| García-Marín, ID | 1 |
| Correa-Basurto, J | 1 |
| Rosales-Hernández, MC | 1 |
| Dumont, M | 1 |
| Stack, C | 1 |
| Elipenhali, C | 1 |
| Calingasan, NY | 1 |
| Wille, E | 1 |
| Beal, MF | 1 |
| Lull, ME | 1 |
| Levesque, S | 1 |
| Surace, MJ | 1 |
| Block, ML | 1 |
| Choi, SH | 1 |
| Aid, S | 1 |
| Kim, HW | 1 |
| Jackson, SH | 1 |
| Bosetti, F | 1 |
| Hashimoto, Y | 1 |
| Tsukamoto, E | 1 |
| Niikura, T | 1 |
| Yamagishi, Y | 1 |
| Ishizaka, M | 1 |
| Aiso, S | 1 |
| Takashima, A | 1 |
| Nishimoto, I | 1 |
6 other studies available for acetovanillone and Alzheimer Disease
| Article | Year |
|---|---|
Glucocorticoid-driven mitochondrial damage stimulates Tau pathology.
Topics: Alzheimer Disease; Animals; Glucocorticoids; Humans; Infant; Mice; Mitochondrial Permeability Transi | 2023 |
Neuroprotective Effects of Apocynin and Galantamine During the Chronic Administration of Scopolamine in an Alzheimer's Disease Model.
Topics: Acetophenones; Alzheimer Disease; Amyloid beta-Peptides; Animals; Cognition; Galantamine; Hippocampu | 2020 |
Apocynin administration does not improve behavioral and neuropathological deficits in a transgenic mouse model of Alzheimer's disease.
Topics: Acetophenones; Alzheimer Disease; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Di | 2011 |
Chronic apocynin treatment attenuates beta amyloid plaque size and microglial number in hAPP(751)(SL) mice.
Topics: Acetophenones; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; En | 2011 |
Inhibition of NADPH oxidase promotes alternative and anti-inflammatory microglial activation during neuroinflammation.
Topics: Acetophenones; Aged; Alzheimer Disease; Animals; ATPases Associated with Diverse Cellular Activities | 2012 |
Amino- and carboxyl-terminal mutants of presenilin 1 cause neuronal cell death through distinct toxic mechanisms: Study of 27 different presenilin 1 mutants.
Topics: Acetophenones; Alzheimer Disease; Animals; Cell Death; Cells, Cultured; Enzyme Inhibitors; Immunoblo | 2004 |